Tony Charman and Catherine Lord answer questions from Spectrum’s webinar on the Lancet Commission’s recommendations for autism research.

The Rett Syndrome Global Registry is gathering data from people around the world with the rare condition to support clinical trials.

The current system to approve genetic and metabolic conditions for newborn screening can’t keep pace with research on new therapies. Don Bailey wants to bring it up to speed.

Excitatory and inhibitory neurons can derive from the same cellular source in the developing human brain, a new study suggests, overturning a 20-year-old hypothesis. Tomasz Nowakowski discusses the finding’s implications for autism research.

The questionnaires used to screen for autism are far from perfect, and tweaking them may not be enough. Roald Øien wants researchers to find better solutions.

Insurance claims data are useful for autism research, but the field needs to standardize how they are mined, Shea says.

Moving most clinical assessments online during the coronavirus pandemic has created a digital divide while closing some geographical ones, say Somer Bishop and Lonnie Zwaigenbaum.

The postmortem brain tissue available for autism research is overwhelmingly from people of Western European heritage. Verónica Martínez-Cerdeño and her colleagues are working to change that.

Hundreds of preschool-aged children in Kentucky began taking antipsychotic medicines in 2012, according to an analysis of Medicaid records. Lohr discusses what it will it take to get them behavioral therapies instead.

Most autistic people do not receive the medically recommended genetic tests for autism. Brenda Finucane and her colleagues want to change that.